Brian Nowosielski

Through pharmacists’ statewide billing capabilities, researchers explore how educational support impacts community pharmacies’ medical billing.

Through the lens of pharmacist satisfaction, researchers assess the implementation and real-world use of medication alert systems.

In part 2, Richard Dion, PharmD, addresses some of the persistent challenges among hospital pharmacies and their pain management models, offering some expert solutions to move forward.

This episode explores PBMs’ copay collection discrepancies and how improper documentation can be the downfall for pharmacy business.

Immunology expert Paul Licciardi, PhD, weighs in on the current state of recommended pneumococcal vaccines and what is on the horizon in the developmental stage.

In part 2, Paul Licciardi, PhD, dives into the evolving need for updated pneumococcal vaccine recommendations and how pharmacists can keep their patients informed.

Richard Dion, PharmD, joins to discuss the growing prominence of opioid stewardship and where the pharmacist can assist in patient programming.

Analyzing nearly a decade of pharmaceutical interventions in community pharmacies, researchers reveal the role pharmacists play in self-medication.

In part 1 of our interview with Paul Licciardi, PhD, he addresses the lowered pneumococcal vaccination age as well as the adult population’s overall relationship with immunization.

With calls to expand access across the health care ecosystem, researchers explore pharmacists' perceptions regarding independent prescribing.

With the Medicare GLP-1 Bridge Program just 2 weeks old, a drug market expert shared their thoughts on what the initiative may mean for pharmacists and their patients.

Among adult patients who have reported a case of invasive pneumococcal disease, researchers address the association of risk factors and recurrent disease.

In this episode, Natalie DiPietro Mager, PharmD, PhD, talks with Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, about how pharmacists can address cannabis use in women during adolescence, reproductive years, and older adulthood.

With GLP-1 questions creating confusion for Medicare patients, pharmacists are becoming the trusted frontline resource, and the stakes for getting it right have never been higher.

With the goal of optimizing long-term weight-loss treatment, researchers gather insights regarding the lived experiences of glucagon-like peptide-1 users.

In an assessment of pharmacy closures, researchers hypothesize underserved neighborhoods would be the most burdened locations across the country.

This episode meanders the time of the year where pharmacy professionals experience a lull in business, providing them with the perfect opportunity to invest in growth.

Jay Bregman, founder and CEO of Andel, discusses the current GLP-1 landscape and how a new Medicare initiative is designed to improve access to this increasingly popular medication class.

Researchers assess how these emerging platforms can support medication use across this patient population.

Within the arena of chronic nonmalignant pain, researchers explore barriers, facilitators, and strategies for opioid optimization services in community pharmacies.

Exploring retail pharmacy data, specifically among Walgreens locations, researchers assess the impact of closures in socially vulnerable areas.

Often operating in the shadows, LTC pharmacy is the backbone of medication management for aging and immunocompromised patients.

Among US adults with and without chronic medical conditions, researchers examine social media use for health-related information.

Prior to the study, researchers report a significant lack of exploration regarding artificial intelligence's use in antimicrobial stewardship programs conducted in pharmacy practice.

In part 2 of our interview, Esmé Grewal, JD, discusses the key opportunities LTC pharmacies possess in assisting the aging population in medication management.

Atacicept-vymj is the first medication for immunoglobulin A nephropathy that targets both B cell activating factor and a proliferation-inducing ligand inhibitors.

Through a secret shopper study, researchers assessed the process for obtaining GLP-1 therapy via the internet and the clinical engagement associated with the purchase.

Researchers assess the impact of various pneumococcal conjugate vaccines since the introduction of immunization programming.

Researchers explore how the prevalence, duration, and characteristics of post-COVID-19 symptoms varied by epidemic period.

Esmé Grewal, JD, joins to discuss the evolution of aging populations in the US and how LTC pharmacies are designed to address older adults’ outcomes.